IBDEI04P ; ; 09-MAY-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 09, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6007,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6007,1,3,0)
 ;;=3^TBI-Closed Wound,LOC < 1hr
 ;;^UTILITY(U,$J,358.3,6007,1,4,0)
 ;;=4^854.12
 ;;^UTILITY(U,$J,358.3,6007,2)
 ;;=^274722
 ;;^UTILITY(U,$J,358.3,6008,0)
 ;;=854.13^^36^396^115
 ;;^UTILITY(U,$J,358.3,6008,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6008,1,3,0)
 ;;=3^TBI-Closed,LOC 1-24hr
 ;;^UTILITY(U,$J,358.3,6008,1,4,0)
 ;;=4^854.13
 ;;^UTILITY(U,$J,358.3,6008,2)
 ;;=^274723
 ;;^UTILITY(U,$J,358.3,6009,0)
 ;;=854.14^^36^396^116
 ;;^UTILITY(U,$J,358.3,6009,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6009,1,3,0)
 ;;=3^TBI-Closed,LOC > 24hr
 ;;^UTILITY(U,$J,358.3,6009,1,4,0)
 ;;=4^854.14
 ;;^UTILITY(U,$J,358.3,6009,2)
 ;;=^274724
 ;;^UTILITY(U,$J,358.3,6010,0)
 ;;=908.3^^36^396^17
 ;;^UTILITY(U,$J,358.3,6010,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6010,1,3,0)
 ;;=3^Carotid Cavernous Fistula,Late Effect
 ;;^UTILITY(U,$J,358.3,6010,1,4,0)
 ;;=4^908.3
 ;;^UTILITY(U,$J,358.3,6010,2)
 ;;=^275249
 ;;^UTILITY(U,$J,358.3,6011,0)
 ;;=368.2^^36^397^24
 ;;^UTILITY(U,$J,358.3,6011,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6011,1,3,0)
 ;;=3^Diplopia
 ;;^UTILITY(U,$J,358.3,6011,1,4,0)
 ;;=4^368.2
 ;;^UTILITY(U,$J,358.3,6011,2)
 ;;=^35208
 ;;^UTILITY(U,$J,358.3,6012,0)
 ;;=695.3^^36^397^2
 ;;^UTILITY(U,$J,358.3,6012,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6012,1,3,0)
 ;;=3^Acne Rosacea
 ;;^UTILITY(U,$J,358.3,6012,1,4,0)
 ;;=4^695.3
 ;;^UTILITY(U,$J,358.3,6012,2)
 ;;=Acne Rosacea^107114
 ;;^UTILITY(U,$J,358.3,6013,0)
 ;;=250.00^^36^397^22
 ;;^UTILITY(U,$J,358.3,6013,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6013,1,3,0)
 ;;=3^DM type II w/o Eye Disease
 ;;^UTILITY(U,$J,358.3,6013,1,4,0)
 ;;=4^250.00
 ;;^UTILITY(U,$J,358.3,6013,2)
 ;;=DM type II w/o Eye Disease^33605
 ;;^UTILITY(U,$J,358.3,6014,0)
 ;;=346.90^^36^397^41
 ;;^UTILITY(U,$J,358.3,6014,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6014,1,3,0)
 ;;=3^Headache,Migraine-Not Intractable
 ;;^UTILITY(U,$J,358.3,6014,1,4,0)
 ;;=4^346.90
 ;;^UTILITY(U,$J,358.3,6014,2)
 ;;=Migraine without Intract^293880
 ;;^UTILITY(U,$J,358.3,6015,0)
 ;;=376.30^^36^397^30
 ;;^UTILITY(U,$J,358.3,6015,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6015,1,3,0)
 ;;=3^Exophthalmos,NOS
 ;;^UTILITY(U,$J,358.3,6015,1,4,0)
 ;;=4^376.30
 ;;^UTILITY(U,$J,358.3,6015,2)
 ;;=Exophthalmos NOS^43683
 ;;^UTILITY(U,$J,358.3,6016,0)
 ;;=368.8^^36^397^7
 ;;^UTILITY(U,$J,358.3,6016,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6016,1,3,0)
 ;;=3^Blurred Vision
 ;;^UTILITY(U,$J,358.3,6016,1,4,0)
 ;;=4^368.8
 ;;^UTILITY(U,$J,358.3,6016,2)
 ;;=Blurred Vision^88172
 ;;^UTILITY(U,$J,358.3,6017,0)
 ;;=362.34^^36^397^5
 ;;^UTILITY(U,$J,358.3,6017,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6017,1,3,0)
 ;;=3^Amaurosis Fugax
 ;;^UTILITY(U,$J,358.3,6017,1,4,0)
 ;;=4^362.34
 ;;^UTILITY(U,$J,358.3,6017,2)
 ;;=^268622
 ;;^UTILITY(U,$J,358.3,6018,0)
 ;;=368.13^^36^397^88
 ;;^UTILITY(U,$J,358.3,6018,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6018,1,3,0)
 ;;=3^Photophobia
 ;;^UTILITY(U,$J,358.3,6018,1,4,0)
 ;;=4^368.13
 ;;^UTILITY(U,$J,358.3,6018,2)
 ;;=^126851
 ;;^UTILITY(U,$J,358.3,6019,0)
 ;;=368.40^^36^397^113
 ;;^UTILITY(U,$J,358.3,6019,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6019,1,3,0)
 ;;=3^Vis Field Defect
 ;;^UTILITY(U,$J,358.3,6019,1,4,0)
 ;;=4^368.40
 ;;^UTILITY(U,$J,358.3,6019,2)
 ;;=^126859
 ;;^UTILITY(U,$J,358.3,6020,0)
 ;;=369.4^^36^397^58
 ;;^UTILITY(U,$J,358.3,6020,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6020,1,3,0)
 ;;=3^Legally Blind,USA Definition
 ;;^UTILITY(U,$J,358.3,6020,1,4,0)
 ;;=4^369.4
 ;;^UTILITY(U,$J,358.3,6020,2)
 ;;=Legal Blindness^268887
 ;;^UTILITY(U,$J,358.3,6021,0)
 ;;=250.01^^36^397^21
 ;;^UTILITY(U,$J,358.3,6021,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6021,1,3,0)
 ;;=3^DM Type I w/o Eye Disease
 ;;^UTILITY(U,$J,358.3,6021,1,4,0)
 ;;=4^250.01
 ;;^UTILITY(U,$J,358.3,6021,2)
 ;;=Diabetes Mellitus Type I^33586
 ;;^UTILITY(U,$J,358.3,6022,0)
 ;;=V08.^^36^397^40
 ;;^UTILITY(U,$J,358.3,6022,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6022,1,3,0)
 ;;=3^HIV Positive
 ;;^UTILITY(U,$J,358.3,6022,1,4,0)
 ;;=4^V08.
 ;;^UTILITY(U,$J,358.3,6022,2)
 ;;=Asymptomatic HIV Status^303392
 ;;^UTILITY(U,$J,358.3,6023,0)
 ;;=921.0^^36^397^16
 ;;^UTILITY(U,$J,358.3,6023,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6023,1,3,0)
 ;;=3^Contusion of Eye
 ;;^UTILITY(U,$J,358.3,6023,1,4,0)
 ;;=4^921.0
 ;;^UTILITY(U,$J,358.3,6023,2)
 ;;=^15052
 ;;^UTILITY(U,$J,358.3,6024,0)
 ;;=379.91^^36^397^87
 ;;^UTILITY(U,$J,358.3,6024,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6024,1,3,0)
 ;;=3^Pain in/around the Eye
 ;;^UTILITY(U,$J,358.3,6024,1,4,0)
 ;;=4^379.91
 ;;^UTILITY(U,$J,358.3,6024,2)
 ;;=Pain in or around eye^89093
 ;;^UTILITY(U,$J,358.3,6025,0)
 ;;=V58.69^^36^397^44
 ;;^UTILITY(U,$J,358.3,6025,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6025,1,3,0)
 ;;=3^Hi-Risk Med,Long Term Current Use
 ;;^UTILITY(U,$J,358.3,6025,1,4,0)
 ;;=4^V58.69
 ;;^UTILITY(U,$J,358.3,6025,2)
 ;;=^303460
 ;;^UTILITY(U,$J,358.3,6026,0)
 ;;=871.4^^36^397^54
 ;;^UTILITY(U,$J,358.3,6026,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6026,1,3,0)
 ;;=3^Laceration of Eyeball
 ;;^UTILITY(U,$J,358.3,6026,1,4,0)
 ;;=4^871.4
 ;;^UTILITY(U,$J,358.3,6026,2)
 ;;=Laceration of Eyeball^274889
 ;;^UTILITY(U,$J,358.3,6027,0)
 ;;=242.90^^36^397^108
 ;;^UTILITY(U,$J,358.3,6027,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6027,1,3,0)
 ;;=3^Thyroid Eye Dis
 ;;^UTILITY(U,$J,358.3,6027,1,4,0)
 ;;=4^242.90
 ;;^UTILITY(U,$J,358.3,6027,2)
 ;;=Thyroid Eye Dis^267811^376.21
 ;;^UTILITY(U,$J,358.3,6028,0)
 ;;=135.^^36^397^101
 ;;^UTILITY(U,$J,358.3,6028,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6028,1,3,0)
 ;;=3^Sarcoidosis
 ;;^UTILITY(U,$J,358.3,6028,1,4,0)
 ;;=4^135.
 ;;^UTILITY(U,$J,358.3,6028,2)
 ;;=Sarcoidosis^107916
 ;;^UTILITY(U,$J,358.3,6029,0)
 ;;=446.5^^36^397^107
 ;;^UTILITY(U,$J,358.3,6029,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6029,1,3,0)
 ;;=3^Temporal Arteritis
 ;;^UTILITY(U,$J,358.3,6029,1,4,0)
 ;;=4^446.5
 ;;^UTILITY(U,$J,358.3,6029,2)
 ;;=Temporal Arteritis^117658
 ;;^UTILITY(U,$J,358.3,6030,0)
 ;;=401.9^^36^397^49
 ;;^UTILITY(U,$J,358.3,6030,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6030,1,3,0)
 ;;=3^Hypertension
 ;;^UTILITY(U,$J,358.3,6030,1,4,0)
 ;;=4^401.9
 ;;^UTILITY(U,$J,358.3,6030,2)
 ;;=Hypertension^186630
 ;;^UTILITY(U,$J,358.3,6031,0)
 ;;=V72.0^^36^397^32
 ;;^UTILITY(U,$J,358.3,6031,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6031,1,3,0)
 ;;=3^Eye Exam
 ;;^UTILITY(U,$J,358.3,6031,1,4,0)
 ;;=4^V72.0
 ;;^UTILITY(U,$J,358.3,6031,2)
 ;;=Eye Exam^43432
 ;;^UTILITY(U,$J,358.3,6032,0)
 ;;=V41.0^^36^397^91
 ;;^UTILITY(U,$J,358.3,6032,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6032,1,3,0)
 ;;=3^Problems with Sight
 ;;^UTILITY(U,$J,358.3,6032,1,4,0)
 ;;=4^V41.0
 ;;^UTILITY(U,$J,358.3,6032,2)
 ;;=^295427
 ;;^UTILITY(U,$J,358.3,6033,0)
 ;;=998.59^^36^397^89
 ;;^UTILITY(U,$J,358.3,6033,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6033,1,3,0)
 ;;=3^Post Op Infection
 ;;^UTILITY(U,$J,358.3,6033,1,4,0)
 ;;=4^998.59
 ;;^UTILITY(U,$J,358.3,6033,2)
 ;;=Post Op Infection^97081
 ;;^UTILITY(U,$J,358.3,6034,0)
 ;;=042.^^36^397^1
 ;;^UTILITY(U,$J,358.3,6034,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6034,1,3,0)
 ;;=3^AIDS,Unspec
 ;;^UTILITY(U,$J,358.3,6034,1,4,0)
 ;;=4^042.
 ;;^UTILITY(U,$J,358.3,6034,2)
 ;;=^266500
 ;;^UTILITY(U,$J,358.3,6035,0)
 ;;=053.29^^36^397^43
 ;;^UTILITY(U,$J,358.3,6035,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6035,1,3,0)
 ;;=3^Herpes Zoster,Oth
 ;;^UTILITY(U,$J,358.3,6035,1,4,0)
 ;;=4^053.29
 ;;^UTILITY(U,$J,358.3,6035,2)
 ;;=^266555
 ;;^UTILITY(U,$J,358.3,6036,0)
 ;;=054.40^^36^397^42
 ;;^UTILITY(U,$J,358.3,6036,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6036,1,3,0)
 ;;=3^Herpes Simplex
 ;;^UTILITY(U,$J,358.3,6036,1,4,0)
 ;;=4^054.40
 ;;^UTILITY(U,$J,358.3,6036,2)
 ;;=^266562
 ;;^UTILITY(U,$J,358.3,6037,0)
 ;;=190.1^^36^397^83
 ;;^UTILITY(U,$J,358.3,6037,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6037,1,3,0)
 ;;=3^Orbit Malig Neoplasm
 ;;^UTILITY(U,$J,358.3,6037,1,4,0)
 ;;=4^190.1
 ;;^UTILITY(U,$J,358.3,6037,2)
 ;;=^267272
 ;;^UTILITY(U,$J,358.3,6038,0)
 ;;=190.2^^36^397^50
 ;;^UTILITY(U,$J,358.3,6038,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6038,1,3,0)
 ;;=3^Lac Gland Malig Neoplasm
 ;;^UTILITY(U,$J,358.3,6038,1,4,0)
 ;;=4^190.2
 ;;^UTILITY(U,$J,358.3,6038,2)
 ;;=^267273
 ;;^UTILITY(U,$J,358.3,6039,0)
 ;;=190.7^^36^397^52
 ;;^UTILITY(U,$J,358.3,6039,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6039,1,3,0)
 ;;=3^Lac Sac Nasolac Malig Neoplasm
 ;;^UTILITY(U,$J,358.3,6039,1,4,0)
 ;;=4^190.7
 ;;^UTILITY(U,$J,358.3,6039,2)
 ;;=^267277
 ;;^UTILITY(U,$J,358.3,6040,0)
 ;;=202.81^^36^397^61
 ;;^UTILITY(U,$J,358.3,6040,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6040,1,3,0)
 ;;=3^Lymphoma,Oth Head,Face,Neck Lymphs
 ;;^UTILITY(U,$J,358.3,6040,1,4,0)
 ;;=4^202.81
 ;;^UTILITY(U,$J,358.3,6040,2)
 ;;=^267496
 ;;^UTILITY(U,$J,358.3,6041,0)
 ;;=215.9^^36^397^85
 ;;^UTILITY(U,$J,358.3,6041,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6041,1,3,0)
 ;;=3^Oth Benign Neoplasm Connect Tissue
 ;;^UTILITY(U,$J,358.3,6041,1,4,0)
 ;;=4^215.9
 ;;^UTILITY(U,$J,358.3,6041,2)
 ;;=^267620
 ;;^UTILITY(U,$J,358.3,6042,0)
 ;;=224.2^^36^397^51
 ;;^UTILITY(U,$J,358.3,6042,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6042,1,3,0)
 ;;=3^Lac Gland,Benign Neoplasm
 ;;^UTILITY(U,$J,358.3,6042,1,4,0)
 ;;=4^224.2
 ;;^UTILITY(U,$J,358.3,6042,2)
 ;;=^267672
 ;;^UTILITY(U,$J,358.3,6043,0)
 ;;=224.5^^36^397^96
 ;;^UTILITY(U,$J,358.3,6043,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6043,1,3,0)
 ;;=3^Retina,Benign Neoplasm
 ;;^UTILITY(U,$J,358.3,6043,1,4,0)
 ;;=4^224.5
 ;;^UTILITY(U,$J,358.3,6043,2)
 ;;=^267675
 ;;^UTILITY(U,$J,358.3,6044,0)
 ;;=224.7^^36^397^28
 ;;^UTILITY(U,$J,358.3,6044,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6044,1,3,0)
 ;;=3^Duct,Sac,Nasolac Benign Neoplasm
